Premarket Mover: Moderna Inc (MRNA) Down 1.67%

Moderna Inc (MRNA) has fallen Friday morning, with the stock falling -1.67% in pre-market trading to 124.5. MRNA's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 127 out of 146 industries, the stock ranks higher than 18% of stocks. Moderna Inc has fallen 1.07% over the past month, closing at $128.73 on June 16. During this period of time, the stock fell as low as $118.29 and as high as $133.17. MRNA has an average analyst recommendation of Buy. The company has an average price target of $214.50.

MRNA has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on MRNA!

See Full MRNA Report

Moderna Inc has a Long-Term Technical rank of 18. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 82% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, MRNA ranks better than 126% of stocks.

Important Dates for Investors in MRNA:

-Moderna Inc is set to release earnings on 8/2/2023. Over the last 12 months, the company has reported EPS of $11.73. -We do not have a set dividend date for Moderna Inc at this time. Click Here To Get The Full Report on Moderna Inc (MRNA)